Recruiting Epilepsy Studies in Augusta
A Study to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy
The purpose of the study is to test the efficacy, safety and tolerability of brivaracetam monotherapy in study participants 2 to 25 years of age inclusive with childhood absence epilepsy (CAE) or juve...
Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures
Primary objective: To evaluate the safety and tolerability of cenobamate in pediatric subjects 2-17 years of age with partial-onset (focal) seizures...
About Epilepsy Clinical Trials in Augusta
Epilepsy is a neurological disorder characterized by recurrent, unprovoked seizures caused by abnormal electrical activity in the brain. It affects about 50 million people worldwide. Treatment includes antiseizure medications, surgery, and neurostimulation devices.
There are currently 2 epilepsy clinical trials recruiting participants in Augusta, GEORGIA. These studies are seeking a combined 300 participants. Research is being sponsored by UCB Biopharma SRL, SK Life Science, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Epilepsy Clinical Trials in Augusta — FAQ
Are there epilepsy clinical trials in Augusta?
Yes, there are 2 epilepsy clinical trials currently recruiting in Augusta, GEORGIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Augusta?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Augusta research site will contact you about next steps.
Are clinical trials in Augusta free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Augusta studies also compensate for your time and travel.
What epilepsy treatments are being tested?
The 2 active trials in Augusta are testing new therapies including novel drugs, biologics, and treatment approaches for epilepsy.
Data updated March 2, 2026 from ClinicalTrials.gov